Physician profile
Omar Awad
NPI 1831393594
$15,562.25
in general payments reported to CMS, 2019-2025
14 companies · $622 in 2025
The $622 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $188 · 2021: $280 · 2022: $14K · 2023: $113 · 2024: $299 · 2025: $622.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,034.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,034.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $12,284.58 | 2021-2025 | |
| Pear Therapeutics (US), INC. | $1,700.00 | 2022 | |
| Inspire Medical Systems, INC. | $401.71 | 2023-2025 | Inspire |
| Zoll Respicardia, INC. | $353.89 | 2019-2023 | Remede System |
| Itamar Medical INC | $255.59 | 2022-2025 | Watchpatone |
| Genzyme Corporation | $204.69 | 2024-2025 | |
| Glaxosmithkline, LLC. | $129.35 | 2019-2024 | Trelegy Ellipta |
| Lilly USA, LLC | $121.84 | 2025 | Zepbound |
| Jazz Pharmaceuticals INC. | $23.08 | 2024 | |
| Insmed, INC. | $22.43 | 2025 | Arikayce |
| Baxter Healthcare | $21.25 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Mallinckrodt Hospital Products INC. | $16.11 | 2025 | Acthar |
| Grifols USA, LLC | $14.12 | 2024 | Prolastin-C Liquid |
| Astrazeneca Pharmaceuticals Lp | $13.61 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omar Awad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.